Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 13.09-1,872.7511.327.3013.65

What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS is 13.09 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202513.09
Mar2024-1,872.75
Mar202311.32
Mar20227.30
Mar202113.65

How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 13.09
Positive
Mar2024 -1872.75
Negative
Mar2023 11.32
55.07
Mar2022 7.3
-46.52
Mar2021 13.65 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹102.9 Cr -0.2% -15.4% -71.8% Stock Analytics
ADANI ENTERPRISES ₹253,405.0 Cr -2% -12.3% -8.1% Stock Analytics
REDINGTON ₹18,332.6 Cr 0.6% -12.8% -2.1% Stock Analytics
HONASA CONSUMER ₹8,754.1 Cr -6.3% -8% 26.1% Stock Analytics
MMTC ₹7,984.5 Cr -2.6% -19.6% 0.8% Stock Analytics
LLOYDS ENTERPRISES ₹7,272.5 Cr 1.3% -17.9% 20.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.2%

-15.4%

-71.8%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses